...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Was checking out SEDAR...

"  Apparently Don is still selling Zenith at a premium to OTC (which is a joke) and a very deep discount (which is also a joke) to the Constellation benchmark."

yep - he sure seems good at making sure theres enough money around for his monthly wage, compensations & keeping a few lights on .... at whatever cost!

Share
New Message
Please login to post a reply